• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

TableMonitoring intervals for people with COAG

Clinical assessmentMonitoring intervals (months)
IOP at target aProgression bOutcome cIOP alone dIOP, optic nerve head and visual field
YesNo eNo change in treatment planNot applicable6 to 12
YesYesReview target IOP and change treatment plan1 to 42 to 6
YesUncertainNo change in treatment planNot applicable2 to 6
NoNo eReview target IOP or change in treatment plan1 to 46 to 12
NoYes / uncertainChange treatment plan1 to 22 to 6
a

IOP at or below target.

b

Progression = increased optic nerve damage and/or visual field change confirmed by repeated test where clinically appropriate.

c

For change of treatment plan refer to treatment recommendations.

d

For people started on treatment for the first time check IOP 1 to 4 months after start of medication.

e

No = not detected or not assessed if IOP check only following treatment change.

IOP at or below target.

Progression = increased optic nerve damage and/or visual field change confirmed by repeated test where clinically appropriate.

For change of treatment plan refer to treatment recommendations.

For people started on treatment for the first time check IOP 1 to 4 months after start of medication.

No = not detected or not assessed if IOP check only following treatment change.

From: 3, Summary of recommendations

Cover of Glaucoma
Glaucoma: Diagnosis and Management of Chronic Open Angle Glaucoma and Ocular Hypertension.
NICE Clinical Guidelines, No. 85.
National Collaborating Centre for Acute Care (UK).
Copyright © 2009, National Collaborating Centre for Acute Care.

Apart from any fair dealing for the purposes of research or private study, criticism or review, as permitted under the Copyright, Designs and Patents Act, 1988, no part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licences issued by the Copyright Licensing Agency in the UK. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.

The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant laws and regulations and therefore for general use.

The rights of National Collaborating Centre for Acute Care to be identified as Author of this work have been asserted by them in accordance with the Copyright, Designs and Patents Act, 1988.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.